LiZhuMD

PubMed

• 22 citations
  OsHAK1 controls the vegetative growth and panicle fertility of rice by its effect on potassium-mediated sugar metabolism
  Guang Chen, Yu Zhang, Banpu Ruan, Longbiao Guo, Dali Zeng, Zhenyu Gao, Li Zhu, Jiang Hu, Deyong Ren, Ling Yu, Guohua Xu, Qian Qian> ;Plant Science. 2018 Sep 1
• 17 citations
  Model-based Phase 3 dose selection for HIV-1 attachment inhibitor prodrug BMS-663068 in HIV-1-infected patients: population pharmacokinetics/pharmacodynamics of the ac...
  Ishani Savant Landry, Li Zhu, Malaz Abu Tarif, Matthew Hruska, Brian M. Sadler, Maria Pitsiu, Samit R Joshi, George J. Hanna, Max Lataillade, David W. Boulton, Richard...> ;Antimicrobial Agents and Chemotherapy. 2016 May 1
• 17 citations
  Pharmacokinetic Interactions between BMS-626529, the Active Moiety of the HIV-1 Attachment Inhibitor Prodrug BMS-663068, and Ritonavir or Ritonavir-Boosted Atazanavir ...
  Li Zhu, Matthew Hruska, Carey Hwang, Vaishali Shah, Michael T. Furlong, George J. Hanna, Richard Bertz, Ishani Savant Landry> ;Antimicrobial Agents and Chemotherapy. 2015 Jul 1
• 11 citations
  Enabled clinical use of an HIV-1 attachment inhibitor through drug delivery.
  Peter Timmins, Jonathan Brown, Nicholas A. Meanwell, George J. Hanna, Li Zhu, John F. Kadow> ;Drug Discovery Today. 2014 Sep 1
• Hypoxia-Targeted siRNA Delivery.
  Perche, F.,Biswas, S.,Wang, T.,Zhu, L.,Torchilin, V. P.> ;Angew. Chem. Int. Ed. Engl.. 2014 Feb 21
• 8 citations
  Randomized placebo-controlled study of the safety, tolerability, antiviral activity, and pharmacokinetics of 10-day monotherapy with BMS-986001, a novel HIV NRTI, in t...
  Laurent Cotte, Pierre Dellamonica, François Raffi, Yazdan Yazdanpanah, Jean-Michel Molina, François Boué, Yasuo Urata, H. Phyllis Chan, Li Zhu, Ih Chang, Richard Bertz...> ;Journal of Acquired Immune Deficiency Syndromes. 2013 Jul 1
• 25 citations
  Pharmacokinetics and pharmacodynamics of atazanavir-containing antiretroviral regimens, with or without ritonavir, in patients who are HIV-positive and treatment-naïve.
  Richard Bertz, Anna Persson, Ellen Chung, Li Zhu, Jenny Zhang, Donnie McGrath, Dennis M. Grasela> ;Pharmacotherapy. 2013 Mar 1
• 102 citations
  In Vitro Antiviral Characteristics of HIV-1 Attachment Inhibitor BMS-626529, the Active Component of the Prodrug BMS-663068
  Beata Nowicka-Sans, Yi-Fei Gong, Brian McAuliffe, Ira B. Dicker, Hsu-Tso Ho, Nannan Zhou, Betsy J. Eggers, Pin-Fang Lin, Neelanjana Ray, Megan Wind-Rotolo, Li Zhu, Ant...> ;Antimicrobial Agents and Chemotherapy. 2012 Jul 1
• 73 citations
  A nucleoside- and ritonavir-sparing regimen containing atazanavir plus raltegravir in antiretroviral treatment-naïve HIV-infected patients: SPARTAN study results.
  Michael J. Kozal, Sergio Lupo, Edwin DeJesus, Jean-Michel Molina, Cheryl McDonald, François Raffi, Jorge Benetucci, Marco Mancini, Rong Yang, Victoria Wirtz, Lisa Perc...> ;HIV Clinical Trials. 2012 May 1
• 18 citations
  Pharmacokinetics and inhibitory quotient of atazanavir/ritonavir versus lopinavir/ritonavir in HIV-infected, treatment-naive patients who participated in the CASTLE Study
  Li Zhu, Shanmei Liao, Michael Child, Jenny Zhang, Anna Persson, Heather Sevinsky, Timothy Eley, Xiaohui Xu, Mark Krystal, Awny Farajallah, Donnie McGrath, Jean-Michel ...> ;The Journal of Antimicrobial Chemotherapy. 2012 Feb 1
• 31 citations
  Effect of Low‐Dose Omeprazole (20 mg Daily) on the Pharmacokinetics of Multiple‐Dose Atazanavir With Ritonavir in Healthy Subjects
  Li Zhu, Anna Persson, Lisa Mahnke, Timothy Eley, Tong Li, Xiaohui Xu, Sangeeta Agarwala, Jeffrey Dragone, Richard Bertz> ;Journal of Clinical Pharmacology. 2011 Mar 1
• 27 citations
  Pharmacokinetics and safety of twice-daily atazanavir 300 mg and raltegravir 400 mg in healthy individuals.
  Li Zhu, Joan R. Butterton, Anna Persson, Michele Stonier, Wendy Comisar, Deborah Panebianco, Sheila Breidinger, Jenny Zhang, Richard Bertz> ;Antiviral Therapy. 2010 Nov 1
• Join now to see all